K vs MRSN · P/E 23, $29.03B cap vs rev $40.5M
Kellanova (K) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
K currently screens at market cap $29.03B and trailing P/E 22.8. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the K and MRSN stock pages for the full models.
Not investment advice.